Skip to main content
CA

Cadrenal Therapeutics

Ponte Vedra Beach, United States
Last funding
$2.5M
Post-IPO EquityApr 2026

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

About Cadrenal Therapeutics

How much funding has Cadrenal Therapeutics raised?

Cadrenal Therapeutics has raised $2.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.

Where is Cadrenal Therapeutics headquartered?

Cadrenal Therapeutics is headquartered in Ponte Vedra Beach, United States.

What does Cadrenal Therapeutics do?

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

What stage is Cadrenal Therapeutics at?

Cadrenal Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cadrenal Therapeutics — Funding & Investors." VCBacked, April 1, 2026, https://www.vcbacked.co/company/cadrenal-therapeutics. Accessed November 14, 2026.
APA
VCBacked. (2026). Cadrenal Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/cadrenal-therapeutics
Wikipedia (cite web)
{{cite web |title=Cadrenal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cadrenal-therapeutics |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Cadrenal Therapeutics? Request a listing update

Founder contacts
m***@cadrenal.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →